Evaluation of the effect of curcumin in coronary hospitalized patients
- Conditions
- coronavirus (covid-19) disease.COVID-19 Diseaseu07.02
- Registration Number
- IRCT20121216011763N52
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Willingness to participate in the study
Age 20-80years
Diagnosis of Covid-19 based on clinical findings and PCR findings
Gastrointestinal tract with normal function and intestinal nutrition criteria
Age less than 20 and more than 80 years
Sensitivity to plant products such as turmeric and pepper
Impossibility of intestinal feeding in the first 48 hours of admission
Patients who are hospitalized in the intensive care unit for less than 48 hours.
Patients who are expected to die within 12 hours of admission to the intensive care unit.
Patients who do not have an indication for intestinal nutrition on the first day and are confirmed and predicted based on the diagnosis of the intensive care unit that they will not be able to receive intestinal nutrition in the future. (Nausea, persistent vomiting, ileus, intestinal obstruction, uncontrolled diarrhea (> 500 ml per day), high-output fistula (> 500 ml per day), intestinal inaccessibility, incomplete resuscitation and hemodynamic instability
Patients with BMI <18.5kg / m2 admitted to the intensive care unit.
Patients who receive nutritional support through complete intravenous feeding
Patients with a history of underlying disease such as congenital and immune disorders, renal and hepatic insufficiency and pancreatitis.Community Verified icon
Taking anticoagulants such as heparin, warfarin, aspirin, etc.
Pregnancy and lactation
Severe septic shock or sepsis
Dissatisfaction of the patient or her legal guardian
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method